Abstract
INTRODUCTION
Minimally invasive aortic valve replacement (MIAVR) was first started through a parasternal approach in the late 1990s [1, 2] . Several approaches for MIAVR have since been introduced, including partial sternotomy (upper, lower, V-shaped and others) and anterior intercostal thoracotomy [3] [4] [5] [6] . In these approaches, the skin incision is commonly created in the anterior chest, so that it is located close to the ascending aorta and aortic valve.
In 2012, we began performing MIAVR through a right axillary longitudinal incision, and we subsequently reported its technical aspects and initial results [7] . This trans-right axillary aortic valve replacement (TAX-AVR) was apparently advantageous in terms of its cosmetic outcome, but it was time consuming because of its remoteness from the ascending aorta and aortic valve.
Minimally invasive valve surgery through a partial sternotomy, parasternal thoracotomy or anterolateral thoracotomy reportedly has excellent outcomes compared with conventional AVR (C-AVR) in terms of a shorter hospital stay and less blood loss [8] [9] [10] [11] .
The aim of this study was to compare the safety and invasiveness of TAX-AVR with those of C-AVR.
MATERIALS AND METHODS

Patient selection
Our institutional review board approved this study and the introduction of TAX-AVR. Written informed consent was obtained from each patient before surgery.
We compared patients who underwent TAX-AVR and C-AVR from January 2007 to June 2016. During this study period, 367 patients underwent isolated AVR at our institution. Of these patients, 112 underwent TAX-AVR, 40 underwent AVR by a right parasternal approach and the remaining 215 patients underwent C-AVR.
Of these 215 patients, we excluded emergency cases and patients who required balloon clamping of the ascending aorta because of heavy calcification. Patients who had undergone a previous cardiac surgery were also excluded. Finally, 183 patients were enrolled in the control group. To compare patients with similar backgrounds, we propensity-matched patients in the TAX-AVR and CAVR groups using age, gender, height, weight, New York Heart Association functional classification, hypertension, diabetes mellitus, hyperlipidaemia, renal function, smoking history, cerebrovascular disease, peripheral vascular disease, chronic obstructive pulmonary disease, history of atrial fibrillation (AF), ejection fraction, infectious endocarditis and myocardial infarction within 90 days as matching factors.
Exclusion criteria for trans-right axillary aortic valve replacement
The following patients were excluded as candidates for TAX-AVR: those with a calcified ascending aorta or femoral artery, those with a severe deformity of the thorax, those undergoing surgery on an emergency basis and those undergoing reoperation.
Operative technique
Trans-right axillary aortic valve replacement. The TAX-AVR technique has been previously reported in detail [7] . Briefly, the patient was placed in the partial left lateral position with the right upper arm flexed anteriorly. A 6-8-cm vertical skin incision was made along the right anterior axillary line, and fatty tissue between the major pectoralis muscle and latissimus dorsi muscle was dissected. An anterolateral thoracotomy was then performed in the third or fourth intercostal space and extended anteriorly underneath the major pectoralis muscle. An endoscope was inserted through the sixth intercostal space. Cardiopulmonary bypass was established through the right groin, and the patient's body temperature was cooled to 32 C. A left ventricular vent was inserted through the right upper pulmonary vein. The ascending aorta was clamped using a flexible clamp (Cygnet Flexible Clamp; Vitalitec, Plymouth, MA, USA), and antegrade cold blood cardioplegia was administered. Additional cold blood cardioplegia was infused through each coronary ostium every 20-25 min.
After resection of the aortic valve, a standard bioprosthesis or mechanical valve was seated using 2-0 braided polyester sutures. All stitches were tied down using a knot pusher. The ascending aorta was closed with a running 4-0 polypropylene suture. After weaning the patient from the cardiopulmonary bypass, the chest was closed in a routine manner. The intraoperative photographs of the TAX-AVR are shown in Fig. 2 .
Conventional aortic valve replacement. After performance of a median sternotomy, cardiopulmonary bypass was established with ascending aortic inflow cannulation and 2-stage or bicaval venous drainage. For myocardial protection, retrograde cold blood cardioplegia was used in addition to antegrade cardioplegia. The remainder of the procedure was performed routinely.
Postoperative care
All patients were transferred to the intensive care unit (ICU) while intubated. They were then extubated and transferred to the ward under the same criteria. The same clinical pathway was applied for postoperative rehabilitation in both groups, and the patients were discharged from the hospital following a typical 7-day postoperative course if their recovery was uneventful. However, chest drain removal differed between the 2 groups. The chest drains were removed when the discharge decreased to <100 ml per 8 h in the TAX-AVR group and to <100 ml/day in the C-AVR group; this is because pericardial effusion could be drained to the thoracic cavity in the TAX-AVR group and cardiac tamponade was unlikely to occur.
Statistical analysis
All data were analysed using SPSS version 22.0 (IBM Corp., Armonk, NY, USA). We propensity-matched patients in the TAX-AVR and CAVR groups using age, gender, height, weight, New York Heart Association functional classification, hypertension, diabetes mellitus, hyperlipidaemia, renal function, smoking history, cerebrovascular disease, peripheral vascular disease, chronic obstructive pulmonary disease, history of AF, ejection fraction, infectious endocarditis and myocardial infarction within 90 days as matching factors. Logistic regression was used, and matching was performed on the logit scale.
The Shapiro-Wilk test was used to check whether the data were normally distributed. The v 2 test and Fisher's exact test were used to compare categorical data, and the t-test or MannWhitney U-test was used for quantitative data. We used 2-sided P-values throughout the study.
The ratio of in-hospital or 30-day mortality and major adverse cardiovascular and cerebral events (MACCE) were set as primary end-points and compared between the 2 groups as safety parameters. Major adverse cardiovascular and cerebral events included myocardial infarction, low output syndrome, thirddegree atrioventricular block and cerebrovascular accident.
The operative time, postoperative ICU stay and postoperative hospital stay were set as secondary end-points. We regarded these as surrogate markers of invasiveness.
RESULTS
No patients in the TAX-AVR group underwent conversion to sternotomy. Therefore, no crossover between the groups occurred.
Before propensity matching, there were some significant differences in patient backgrounds between the 2 groups ( Table 1 ). The C-AVR group contained significantly more males, smokers and patients with a history of AF. The average left ventricular ejection fraction tended to be worse in the C-AVR group. The numbers of patients with diabetes mellitus and renal failure tended to be higher in the C-AVR group.
Propensity matching between patients in the TAX-AVR and C-AVR groups generated 108 matched pairs. After matching, there were no longer any significant differences in background characteristics between the 2 groups ( Table 2) .
Primary end-points
With the exception of reoperation for bleeding, there were no significant differences in hospital death or major adverse cardiovascular and cerebral events between the 2 groups (Table 3) . Operative/30-day mortality was observed in 1 patient in the C-AVR group. This was the only mortality in both groups, including before matching. This 73-year-old woman died of sepsis caused by a psoas muscle abscess. Of the 3 patients who developed stroke after TAX-AVR, 1 had disabling stroke and 2 recovered almost fully.
Secondary end-points
The operation time was shorter in the TAX-AVR group. In contrast, the aortic cross-clamp time was longer in the TAX-AVR group (Table 4) . The ICU stay and postoperative hospital stay were both significantly shorter in the TAX-AVR group.
Other results
The incidence of new-onset AF was significantly lower in the TAX-AVR group. The bleeding volume during the first 24 h postoperatively was lower in the TAX-AVR group. The number of units of blood transfused per patient was also lower in the TAX-AVR group. There was no significant difference in the average size of the prosthesis implanted between the 2 groups (Table 4) .
DISCUSSION
TAX-AVR has an apparent cosmetic advantage as shown in Fig. 1 . The major scar is located at the right armpit and is almost hidden once the right upper arm is lowered. Another benefit of this approach is preservation of major muscles of the thoracic wall and right internal mammary artery. This approach can also prevent injury of the mammary gland in women. At first, we performed minimally invasive AVR with a right parasternal approach. However, the position of the ascending aorta and aortic valve differed among patients, sometimes making the procedure more difficult. TAX-AVR is superior to other minimally invasive approaches with respect to less variation in visualization because of the long distance between the chest wall and aortic valve. Despite these advantages, there are some concerns about the safety, invasiveness and quality of surgery of TAX-AVR because of the remoteness from the ascending aorta and aortic valve. Additionally, all sutures must be tied with a knot pusher, and endoscopic assistance is necessary. These factors necessarily lead to a longer procedural time.
In the present study, propensity-matched comparison between TAX-AVR and C-AVR showed no significant differences in the safety parameters as primary end-points. Therefore, TAX-AVR appears to be as safe as C-AVR as a benchmark. With respect to invasiveness, the operation time and aortic clamp time showed mixed results. Minimal invasiveness may also be associated with a shorter CPB time and cross-clamp time. However, this TAX-AVR procedure is highly beneficial. The postoperative ICU stay and hospital stay were significantly shorter in the TAX-AVR group, implying quicker recovery than after C-AVR.
Compared with other MIAVR approaches [8] [9] [10] [11] , TAX-AVR is time consuming, but it also shows advantages over C-AVR. Furthermore, the CPB time and cross-clamp time of the more recent TAX-AVR procedures was about 20 min shorter than those of previous cases. Thus, continued improvement and practice of this procedure will further improve the minimal invasiveness of TAX-AVR. According to a previous comparison between forechest minithoracotomy AVR and C-AVR, TAX-AVR is associated with a shorter postoperative course, lower incidence of newonset AF and less need for blood products [10, 11] .
In the present study, the rate of cerebrovascular accidents in C-AVR was twice that of TAX-AVR (5.6% vs 2.8%, respectively). This is probably because of the patient selection bias. Patients with more severe vascular calcification tended to undergo C-AVR and may have also had cerebrovascular arteriosclerosis. In addition, the mean number of transfusion units in the C-AVR group was 4.7 per patient but that in the TAX-AVR group was almost 3.0 per patient. This difference of 2 units between the 2 groups may have resulted from continuous bleeding through the sternal marrow.
The quality of the surgery seemed to be preserved in the TAX-AVR group. The mean prosthesis size was equal in both groups (22.0 mm for an average body surface of 1.52 m 2 in the TAX-AVR group). Annular patch enlargement was also possible in the TAX-AVR group. No significant perivalvular leakage occurred even when remote tying was performed using a knot pusher.
Limitations
This study has several limitations. First, it was a single-institution, retrospective study. The operative period differed between the TAX-AVR and C-AVR groups: C-AVR was predominantly performed in the first half of the study period and TAX-AVR was started in 2012. However, the chief surgeon was unchanged during this period.
Second, in the C-AVR group, the average aortic clamp time, cardiopulmonary bypass time and operation time were longer than expected. We did not include differences among surgeons as a matching factor. Although commonly used risk models such as the European System for Cardiac Operative Risk Evaluation score and Society of Thoracic Surgeons score do not include operator-or institution-related factors, there is usually a substantial difference in the procedural time between consultant surgeons and trainees. Fifteen different trainees were involved as the main operator for 126 of 183 patients in the C-AVR group, and isolated C-AVR was the primary cardiac operation with which the trainees started. In contrast, 111 of 112 patients in the TAX-AVR group underwent operations by 2 consultant surgeons (T.I. and A.M.). These differences were inevitable when both the training of the surgeons and safety of the patients were considered. Saxena et al. [12] reported data on the aortic clamp time and perfusion time during isolated C-AVR from the Australasian Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database Program from 2001 to 2009. Trainee cases had a longer mean perfusion time (117.9 vs 98.9 min) and cross-clamp time (88.8 vs 73.2 min), but the clinical outcomes showed no differences. Similarly, in our study, the dominance of trainee cases in the C-AVR group may have favoured comparably better outcomes in the TAX-AVR group but the impact was probably not critical.
CONCLUSION
In conclusion, although TAX-AVR is not yet a surgery for every surgeon, it is as safe as C-AVR and seems to be less invasive because of its shorter postoperative course than C-AVR.
Funding
This study was performed by own departmental resources and no Funding or Grants have been received.
